NCT04061889UnknownNot Applicable
Clinical Epidemiology Cohort Study for Patient Living With HIV
Kaohsiung Veterans General Hospital.1 site in 1 country2,000 target enrollmentStarted: April 1, 2019Last updated:
Conditions
Trial Snapshot
- Phase
- Not Applicable
- Enrollment
- 2,000
- Locations
- 1
- Primary Endpoint
- Hazard ratio of cohort epidemiology characteristics in treatment failure, renal failure and hepatitis D coinfection
Study Overview
Brief Summary
This is a retrospective observational cohort study for the patient living with HIV aiming to understand more in disease progress, resistant mutation, comorbidity, and common coinfection.
Study Design
- Study Type
- Observational
- Observational Model
- Cohort
- Time Perspective
- Retrospective
Eligibility Criteria
- Ages
- 20 Years to — (Adult, Older Adult)
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •Patient living with HIV receiving follow-up in Kaohsiung VGH
Exclusion Criteria
- •not applicable
Outcomes
Primary Outcomes
Hazard ratio of cohort epidemiology characteristics in treatment failure, renal failure and hepatitis D coinfection
Time Frame: on average of 3 year
Secondary Outcomes
No secondary outcomes reported
Investigators
Hung Chin Tsai
Visiting Physician
Kaohsiung Veterans General Hospital.
Study Sites (1)
Loading locations...
Similar Trials
Recruiting
Not Applicable
Cohort Study of HIV-positive People, Treated With Long Acting Antiretroviral TherapyHIV InfectionsNCT05663580Castagna Antonella1,500
Completed
Not Applicable
A Study of the Long-Term Outcomes of HIV-Positive PatientsHIV InfectionsNCT00000932National Institute of Allergy and Infectious Diseases (NIAID)3,669
Completed
Not Applicable
A Study to Monitor Patients With Primary or Early HIV InfectionHIV InfectionsNCT00000911National Institute of Allergy and Infectious Diseases (NIAID)1,500
Recruiting
Not Applicable
Clinical and Immunologic Monitoring of Patients With Known or Suspected HIV InfectionHIVNCT00789009National Institute of Allergy and Infectious Diseases (NIAID)600
Completed
Phase 1
Long-term Follow-up of Participants From Studies Evaluating GSK HIV VaccineAIDSNCT01092611GlaxoSmithKline190
